{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:46:02Z","timestamp":1783741562713,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,7]],"date-time":"2014-12-07T00:00:00Z","timestamp":1417910400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s13760-014-0399-3","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T09:40:07Z","timestamp":1418031607000},"page":"471-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lafora disease: psychiatric manifestations, cognitive decline, and visual hallucinations"],"prefix":"10.1007","volume":"115","author":[{"given":"Ri\u00ebm","family":"El Tahry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"de Tourtchaninoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Vrielynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenou","family":"Van Rijckevorsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,7]]},"reference":[{"key":"399_CR1","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-84628-644-5","volume-title":"A clinical guide to Epileptic Syndromes and their treatment. Revised second edition","author":"CP Panayiotopoulos","year":"2010","unstructured":"Panayiotopoulos CP (2010) A clinical guide to Epileptic Syndromes and their treatment. Revised second edition. Springer healthcare Ltd, Germany"},{"issue":"7","key":"399_CR2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2165\/11319250-000000000-00000","volume":"24","author":"TS Monoghan","year":"2010","unstructured":"Monoghan TS, Delanty N (2010) Lafora disease: epidemiology, pathophysiology and management. CNS Drugs 24(7):549\u2013561","journal-title":"CNS Drugs"},{"key":"399_CR3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s004150050048","volume":"244","author":"DR Footitt","year":"1997","unstructured":"Footitt DR, Quin N, Kocen RS et al (1997) Familial lafora body disease of late onset: report of four cases in one family and a review of the literature. J Neurol 244:40\u201344","journal-title":"J Neurol"},{"issue":"11","key":"399_CR4","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/01.WNL.0000096017.19978.CB","volume":"61","author":"DM Andrade","year":"2003","unstructured":"Andrade DM, Ackerley CA, Minett TS et al (2003) Skin biopsy in lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology 61(11):1611\u20131614","journal-title":"Neurology"},{"key":"399_CR5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.0b013e31825dcdac","volume":"79","author":"J-M Giard","year":"2012","unstructured":"Giard J-M, Stone SSD, Lohi H et al (2012) Phosphorylation prevents polyglucosan transport in Lafora disease. Neurology 79:100\u2013102","journal-title":"Neurology"},{"key":"399_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0887-8994(00)00276-9","volume":"25","author":"BA Minassian","year":"2001","unstructured":"Minassian BA (2001) Lafora\u2019s disease: towards a clinical, pathologic, and molecular synthesis. Pediatr Neurol 25:21\u201329","journal-title":"Pediatr Neurol"},{"key":"399_CR7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneur.1993.00540010096025","volume":"50","author":"I Drury","year":"1993","unstructured":"Drury I, Blaivias M, Abou-Khalil B, Beydoun A (1993) Biopsy results in a kindred with Lafora disease. Arch Neurol 50:102\u2013105","journal-title":"Arch Neurol"},{"issue":"Suppl. 9","key":"399_CR8","first-page":"13","volume":"49","author":"V Antonio","year":"2008","unstructured":"Antonio V, Delgado-Escueta, Blaise FD Bourgeois (2008) Does genetic information in humans help us to treat patients? Epilepsia 49(Suppl. 9):13\u201324","journal-title":"Epilepsia"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-014-0399-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-014-0399-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-014-0399-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T12:56:36Z","timestamp":1559480196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-014-0399-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,7]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1007\/s13760-014-0399-3","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,7]]}}}